Under normal conditions, prolyl hydroxylase (PHD) targets HIF-1α for degradation; however, reduced PHD activity in tumors stabilizes HIF-1α, resulting in its accumulation and the subsequent promotion of glycolysis to support tumor growth [235]. The gene discussed is PDC; the disease is neoplasm.